Endothelial Dysfunction in the Development of Aortic Degeneration, Dissection, and Rupture

主动脉变性、夹层和破裂中的内皮功能障碍

基本信息

  • 批准号:
    10539531
  • 负责人:
  • 金额:
    $ 66.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-15 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Ascending thoracic aortic aneurysms and dissections (ATAAD) are extremely lethal diseases. The contribution of endothelial dysfunction in ATAAD has received limited attention and thus remains poorly understood. Com- pelling evidence from our preliminary studies suggests a critical role for endothelial cell (EC) injury and endo- thelial hyperpermeability in aortic degeneration and ATAAD development. [scRNA-seq analysis of aortas from sporadic ATAAD patients revealed significant EC dysfunction with upregulation of RIP3 and GSDMD that trig- ger necroptosis and pyroptosis, respectively. In a sporadic ATAAD mouse model, aortic challenge with high- fat diet and angiotensin II infusion induced RIP3 and GSDMD in ECs, caused endothelial hyperpermeability, nanoparticle infiltration, interlaminar space expansion, elastic fiber delamination, and microdissection. EC-Rip3- /- or EC-Gsdmd-/- showed markedly reduced nanoparticle infiltration and aortic degeneration.] Further investiga- tion with scATAC-seq showed that aortic challenge increased chromatin accessibility at promoters/enhancers of the pro-inflammatory/pro-death genes, likely by activating pro-inflammatory transcription factors (TFs) such as IRF3. In human ECs, cytosolic DNA and STING-TBK1 signaling was a potent upstream trigger for the acti- vation of IRF3 and BRG1 and induction of GSDMD expression. The objective of this application is to test the central hypothesis that aortic stress activates inflammatory signaling within ECs that triggers epigenetic in- duction of a pro-inflammatory and pro-death program, leading to EC necroptosis/pyroptosis, barrier dysfunc- tion, blood component infiltration, aortic wall degeneration, and ATAAD formation. [Aim 1 will test the hypothe- sis that RIP3-mediated EC necroptosis and GSDMD-mediated EC pyroptosis compromise EC barrier function, thereby facilitating the infiltration of inflammatory blood components and promoting aortic degeneration and ATAAD formation. In our sporadic ATAAD model, we will compare aortic degeneration and ATAAD formation in control mice, EC-Rip3-/- mice, EC-Gsdmd-/- mice, and WT mice treated with a necroptosis/pyroptosis inhibi- tor.] Aim 2 will test the hypothesis that aortic stress activates inflammatory signaling (e.g., STING pathway) within ECs that triggers epigenetic induction of a pro-inflammatory and pro-death program. We will perform scRNA-seq and scATAC-seq analyses of ECs in aortas from unchallenged and challenged WT mice and EC- specific Sting KO mice. Aim 3 will test the hypothesis that stress signals (e.g., cytosolic DNA) trigger sensing- signaling pathways (e.g., STING-TBK) that directly activates chromatin remodeling complexes (e.g., BRG1/SWI/SNF) and TFs (e.g., IRF3) that induce GSDMD expression and promote EC pyroptosis. We will test the hypothesis in cultured human ECs (Aim 3A) and [confirm the mechanistic links in human ATAAD aortas (Aim 3B)]. We expect that the proposed studies will provide novel insight into the molecular mechanisms of sporadic aortic degeneration and ATAAD formation, which will in turn enable development of new treatments for preventing disease progression and its fatal sequelae. 1
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KETAN B Ghaghada其他文献

KETAN B Ghaghada的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KETAN B Ghaghada', 18)}}的其他基金

Endothelial Dysfunction in the Development of Aortic Degeneration, Dissection, and Rupture
主动脉变性、夹层和破裂中的内皮功能障碍
  • 批准号:
    10662568
  • 财政年份:
    2022
  • 资助金额:
    $ 66.21万
  • 项目类别:
MULTI-SPECTRAL IMAGING OF ATHEROSCLEROSIS
动脉粥样硬化的多光谱成像
  • 批准号:
    8363182
  • 财政年份:
    2011
  • 资助金额:
    $ 66.21万
  • 项目类别:
PHARMACOKINETICS OF LIPOSOMAL-IODINATED CONTRAST AGENTS IN MICE-MICRO-CT
脂质体碘化造影剂在小鼠显微 CT 中的药代动力学
  • 批准号:
    8363173
  • 财政年份:
    2011
  • 资助金额:
    $ 66.21万
  • 项目类别:
PHARMACOKINETICS OF LIPOSOMAL-IODINATED CONTRAST AGENTS IN MICE--MICRO-CT
脂质体碘化造影剂在小鼠体内的药代动力学--Micro-CT
  • 批准号:
    8171598
  • 财政年份:
    2010
  • 资助金额:
    $ 66.21万
  • 项目类别:
MULTI-SPECTRAL IMAGING OF ATHEROSCLEROSIS
动脉粥样硬化的多光谱成像
  • 批准号:
    8171611
  • 财政年份:
    2010
  • 资助金额:
    $ 66.21万
  • 项目类别:
PHARMACOKINETICS OF LIPOSOMAL-IODINATED CONTRAST AGENTS IN MICE--MICRO-CT
脂质体碘化造影剂在小鼠体内的药代动力学--Micro-CT
  • 批准号:
    7956941
  • 财政年份:
    2009
  • 资助金额:
    $ 66.21万
  • 项目类别:

相似海外基金

Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
  • 批准号:
    493141
  • 财政年份:
    2023
  • 资助金额:
    $ 66.21万
  • 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
  • 批准号:
    10734120
  • 财政年份:
    2023
  • 资助金额:
    $ 66.21万
  • 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
  • 批准号:
    10707997
  • 财政年份:
    2022
  • 资助金额:
    $ 66.21万
  • 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
  • 批准号:
    RGPIN-2016-04414
  • 财政年份:
    2022
  • 资助金额:
    $ 66.21万
  • 项目类别:
    Discovery Grants Program - Individual
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
  • 批准号:
    10555926
  • 财政年份:
    2022
  • 资助金额:
    $ 66.21万
  • 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
  • 批准号:
    RGPIN-2016-04414
  • 财政年份:
    2021
  • 资助金额:
    $ 66.21万
  • 项目类别:
    Discovery Grants Program - Individual
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
  • 批准号:
    445961
  • 财政年份:
    2021
  • 资助金额:
    $ 66.21万
  • 项目类别:
    Operating Grants
Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury
近曲小管中的管内血管紧张素 II 和 AT1a 受体:在高血压和肾损伤中的作用
  • 批准号:
    10164776
  • 财政年份:
    2020
  • 资助金额:
    $ 66.21万
  • 项目类别:
Novel Roles of Mitochondrial Angiotensin II in The Proximal Tubule of The Kidney
线粒体血管紧张素 II 在肾近端小管中的新作用
  • 批准号:
    10251271
  • 财政年份:
    2020
  • 资助金额:
    $ 66.21万
  • 项目类别:
Metabolic and epigenetic regulation of cancer associated fibroblasts by angiotensin II
血管紧张素 II 对癌症相关成纤维细胞的代谢和表观遗传调控
  • 批准号:
    440714
  • 财政年份:
    2020
  • 资助金额:
    $ 66.21万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了